Skip to main content
. 2022 Apr 20;170:149–157. doi: 10.1016/j.ejca.2022.04.008

Table 2.

Side effects across doses

Effects after 1st shot n (%)
 Yes 226 (36.3%)
 No 397 (63.7%)
Type of effect after 1st shot n (%)
 Pain injection site 129 (57.1%)
 Fatigue 34 (15.1%)
 Paresthesia 1 (0.4%)
 Myalgia 13 (5.8%)
 Fever <37.9 14 (6.2%)
 Headache 18 (8%)
 Fever >38 5 (2.2%)
 Shivers 1 (0.4%)
 Injection-site redness 1 (0.4%)
 Hives 1 (0.4%)
 Other 9 (4%)
Severity of side effect after 1st shot mean ± SD 0.43 ± 0.63
 No effect 397 (63.7%)
 Mild 184 (29.5%)
 Moderate 40 (6.4%)
 Severe 2 (0.3%)
Effects after 2nd shot n (in %) 281 (46%)
 Yes 329 (54%)
 No
Type of effect after 2nd shot n (in %)
 Pain inoculation point 20 (7.1%)
 Fatigue 24 (8.5%)
 Myalgia 52 (18.5%)
 Fever <37.9 99 (35.2%)
 Headache 32 (11.4%)
 Fever >38 27 (9.6%)
 Shivers 18 (6.4%)
 Inoculation point redness 1 (0.4%)
 Hives 1 (0.4%)
 Other 7 (2.5%)
Severity of side effect after 2nd shot mean ± SD 0.90 ± 0.75
 No effect 329 (54%)
 Mild 209 (34.2%)
 Moderate 62 (10.2%)
 Severe 10 (1.6%)
Effects after 3rd shot n (in %)
 Yes 172 (51.3%)
 No 163 (48.7%)
Type of effect after 3rd shot n (in %)
 Pain inoculation point 58 (33.7%)
 Fatigue 6 (3.5%)
 Myalgia 20 (11.6%)
 Fever <37.9 42 (24.4%)
 Headache 6 (3.5%)
 Fever >38 53 (30.8%)
 Shivers 2 (1.2%)
 Other 1 (0.6%)
Severity of side effect after 3rd shot mean ± SD 0.63 ± 0.94
 No effect 163 (49%)
 Mild 57 (17%)
 Moderate 91 (27%)
 Severe 24 (7%)